RU2013145233A - MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX - Google Patents

MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX Download PDF

Info

Publication number
RU2013145233A
RU2013145233A RU2013145233/15A RU2013145233A RU2013145233A RU 2013145233 A RU2013145233 A RU 2013145233A RU 2013145233/15 A RU2013145233/15 A RU 2013145233/15A RU 2013145233 A RU2013145233 A RU 2013145233A RU 2013145233 A RU2013145233 A RU 2013145233A
Authority
RU
Russia
Prior art keywords
nanoparticles
porphyrin complex
diagnosis
diagnostic
magnetometric
Prior art date
Application number
RU2013145233/15A
Other languages
Russian (ru)
Inventor
Владимир Николаевич Никифоров
Виктор Геннадьевич Средин
Андрей Валентинович Иванов
Валентина Дмитриевна Румянцева
Original Assignee
Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования Военная академия Ракетных войск стратегического назначения имени Петра Великого МО РФ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования Военная академия Ракетных войск стратегического назначения имени Петра Великого МО РФ filed Critical Федеральное государственное казенное военное образовательное учреждение высшего профессионального образования Военная академия Ракетных войск стратегического назначения имени Петра Великого МО РФ
Priority to RU2013145233/15A priority Critical patent/RU2013145233A/en
Publication of RU2013145233A publication Critical patent/RU2013145233A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Магнитометрический способ диагностики онкологических заболеваний с помощью наночастиц Yb-порфиринового комплекса, основанный на введении наночастиц указанного комплекса в исследуемую ткань и регистрации сигнала от злокачественных тканей, отличающийся тем, что, с целью повышения точности диагностики и уменьшения дозы вводимого контрастного вещества, регистрируют магнитный отклик, обусловленный магнетизмом иона Yb, селективно накопленного в ткани в результате ее малигнизации.A magnetometric method for the diagnosis of cancer using nanoparticles of the Yb-porphyrin complex, based on the introduction of nanoparticles of the specified complex into the test tissue and registration of a signal from malignant tissues, characterized in that, in order to increase the accuracy of diagnosis and reduce the dose of the injected contrast agent, the magnetic response is recorded, due to the magnetism of the Yb ion, selectively accumulated in the tissue as a result of its malignancy.

Claims (1)

Магнитометрический способ диагностики онкологических заболеваний с помощью наночастиц Yb-порфиринового комплекса, основанный на введении наночастиц указанного комплекса в исследуемую ткань и регистрации сигнала от злокачественных тканей, отличающийся тем, что, с целью повышения точности диагностики и уменьшения дозы вводимого контрастного вещества, регистрируют магнитный отклик, обусловленный магнетизмом иона Yb, селективно накопленного в ткани в результате ее малигнизации. A magnetometric method for the diagnosis of cancer using nanoparticles of the Yb-porphyrin complex, based on the introduction of nanoparticles of the specified complex into the test tissue and registration of a signal from malignant tissues, characterized in that, in order to increase the accuracy of diagnosis and reduce the dose of the injected contrast agent, the magnetic response is recorded, due to the magnetism of the Yb ion, selectively accumulated in the tissue as a result of its malignancy.
RU2013145233/15A 2013-10-09 2013-10-09 MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX RU2013145233A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2013145233/15A RU2013145233A (en) 2013-10-09 2013-10-09 MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013145233/15A RU2013145233A (en) 2013-10-09 2013-10-09 MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX

Publications (1)

Publication Number Publication Date
RU2013145233A true RU2013145233A (en) 2015-04-20

Family

ID=53282650

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013145233/15A RU2013145233A (en) 2013-10-09 2013-10-09 MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX

Country Status (1)

Country Link
RU (1) RU2013145233A (en)

Similar Documents

Publication Publication Date Title
PH12017502205A1 (en) New gadolinium chelate compounds for use in magnetic resonance imaging
MX2021008976A (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer.
BR112016002000A2 (en) CANCER DIAGNOSIS AND THERAPY INVOLVING TUMOR STEM CELLS
EA201690549A1 (en) ARILETHER AND THEIR APPLICATION
MX2018007043A (en) Dimeric contrast agents.
BR112012020304A2 (en) tissue targeting complex, use of a tissue targeting complex, method of treating a human or non-human animal body, pharmaceutical composition, and kit
PH12015500252A1 (en) Niclosamide for the treatment of solid tumors
SA518391121B1 (en) 18f-tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer
MX362675B (en) Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer.
NZ710436A (en) Biospecific agents for bone
EP3060260A4 (en) Methods and diagnostic kit for visualizing body tissues and components therein
ES2540255A1 (en) Method of isolation of apoptotic bodies (Machine-translation by Google Translate, not legally binding)
WO2015081283A3 (en) Long non-coding rna as a diagnostic and therapeutic agent
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
UY37500A (en) NEW GADOLIN CHELATE COMPOUNDS WITH HIGH RELAXIVITY TO USE IN THE OBTAINING OF IMAGES BY MAGNETIC RESONANCE
MX2018016082A (en) Chelate compounds.
CO6592030A2 (en) Use of ventricular dilation rate in the treatment of Alzheimer's disease with intravenous immunoglobulin
MX2016006584A (en) Methods and compositions for treating amyloid deposits.
RU2013145233A (en) MAGNETOMETRIC METHOD FOR DIAGNOSTIC OF ONCOLOGICAL DISEASES USING NANOPARTICLES OF Yb-PORPHYRIN COMPLEX
WO2015023694A3 (en) Method for enhancing tumor growth
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer
Epstein Re: Editorial comment on urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection (Health Aff [Millwood] 2012; 31: 741-749): PC Walsh J Urol 2012; 188: 1767
Decelle et al. Evaluation of prostate cancer metabolomic field effects using prostate needle biopsies
RU2013156065A (en) METHOD FOR PRODUCING MATERIAL FOR DIAGNOSTIC OF GLIAL BRAIN NORMAL FORMATIONS
UA75720U (en) method for liver biopsy in farming sheep

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20150629